Effects of lactational administration of acrylamide on rat dams and offspring

被引:39
作者
Friedman, MA
Tyl, RW
Marr, MC
Myers, CB
Gerling, FS
Ross, WP
机构
[1] Res Triangle Inst, Res Triangle Pk, NC 27709 USA
[2] Univ Med & Dent New Jersey, Newark, NJ 07103 USA
关键词
acrylamide monomer; offspring effects during lactation; maternal Wistar rats; postwean offspring effects; oral lactational exposure; functional observational battery; maternal neurotoxicity; fore- and hindlimb grip strength;
D O I
10.1016/S0890-6238(99)00043-X
中图分类号
Q [生物科学];
学科分类号
07 [理学]; 0710 [生物学]; 09 [农学];
摘要
We duplicated the study design of Husain et al. (Ind Health 1987; 25:19-28) to determine whether maternal exposure to acrylamide monomer (AM) resulted in offspring neurotoxicity. Wistar rat dams with litters (15/group) were gavaged with AM in saline at 0 or 25.0 mg/kg/d throughout lactation (pnd 0-21). Maternal feed and water consumption, body weights (BW), and Functional Observational Battery (FOB) were recorded. At weaning (pnd 21), maternal sciatic nerves were examined histologically. Male offspring were retained until pnd 91, with BW and grip strength evaluations. Dosed dams exhibited progressive toxicity, including mortality (two), severely reduced feed and water consumption, BW, and BW gain, and behavioral neurotoxicity (with no sciatic nerve pathology). Nursing offspring at 25.0 mg/kg/d exhibited increased mortality and reduced BW associated with little/no milk in stomachs. Postwean males at 25.0 mg/kg/d exhibited normal BW gain and increasing grip strength over time. Therefore, AM caused maternal toxicity; offspring effects during lactation were consistent with inanition from maternal toxicity. Postwean males exhibited recovery with no signs of AM-mediated toxicity. These results do not support the conclusions of Husain et al. (C) 1999 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:511 / 520
页数:10
相关论文
共 31 条
[1]
[Anonymous], SAS STAT US GUID VER
[2]
BUREK JD, 1980, J ENVIRON PATHOL TOX, V4, P157
[4]
DISTRIBUTION AND BINDING OF [C-14] ACRYLAMIDE TO MACROMOLECULES IN SENCAR AND BALB/C MICE FOLLOWING ORAL AND TOPICAL ADMINISTRATION [J].
CARLSON, GP ;
WEAVER, PM .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1985, 79 (02) :307-313
[5]
INVIVO BINDING OF [C-14] ACRYLAMIDE TO PROTEINS IN THE MOUSE NERVOUS-SYSTEM [J].
CARRINGTON, CD ;
LAPADULA, DM ;
DULAK, L ;
FRIEDMAN, M ;
ABOUDONIA, MB .
NEUROCHEMISTRY INTERNATIONAL, 1991, 18 (02) :191-197
[6]
THE REPRODUCTIVE AND NEURAL TOXICITIES OF ACRYLAMIDE AND 3 ANALOGS IN SWISS MICE, EVALUATED USING THE CONTINUOUS BREEDING PROTOCOL [J].
CHAPIN, RE ;
FAIL, PA ;
GEORGE, JD ;
GRIZZLE, TB ;
HEINDEL, JJ ;
HARRY, GJ ;
COLLINS, BJ ;
TEAGUE, J .
FUNDAMENTAL AND APPLIED TOXICOLOGY, 1995, 27 (01) :9-24
[7]
SOME METHODS FOR STRENGTHENING THE COMMON X2 TESTS [J].
COCHRAN, WG .
BIOMETRICS, 1954, 10 (04) :417-451
[8]
FRIEDMAN MA, 1998, UNPUB REPROD TOXICOL
[9]
NEUROTOXICITY OF ACRYLAMIDE IN DEVELOPING RAT-BRAIN - CHANGES IN THE LEVELS OF BRAIN BIOGENIC-AMINES AND ACTIVITIES OF MONOAMINE-OXIDASE AND ACETYLCHOLINE ESTERASE [J].
HUSAIN, R ;
DIXIT, R ;
DAS, M ;
SETH, PK .
INDUSTRIAL HEALTH, 1987, 25 (01) :19-28
[10]
Biochemical and morphologic characterization of acrylamide peripheral neuropathy [J].
Lehning, EJ ;
Persaud, A ;
Dyer, KR ;
Jortner, BS ;
LoPachin, RM .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1998, 151 (02) :211-221